Gilead Sciences v. Academy of Military Medical Sciences — UPC Revokes Chinese Military Institute’s Remdesivir COVID-19 Patent for Lack of Inventive Step
The UPC Central Division in Milan revoked the Academy of Military Medical Sciences’ European patent on the use of remdesivir to treat COVID-19, finding the claimed invention lacked inventive step because prior art published just ten days before the priority date already identified remdesivir a